| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.06 | 0.3 |